Efficacy and safety of oral decitabine/cedazuridine in the chronic myelomonocytic leukaemia subpopulations from phase 2 and 3 studies

Documenti analoghi

• Oral decitabine/cedazuridine versus intravenous decitabine for acute myeloid leukaemia: A randomised, crossover, registration, pharmacokinetics study
  di: Klaus Geissler, et al.
  Pubblicazione: (2024)
• Oral decitabine–cedazuridine in acute myeloid leukaemia
  di: Ian M. Bouligny, et al.
  Pubblicazione: (2024)
• Chronic myelomonocytic leukaemia
  di: Ayalew Tefferi, et al.
  Pubblicazione: (2025)
• Facial pustular eruption of chronic myelomonocytic leukaemia
  di: Ying Zhao, et al.
  Pubblicazione: (2026)
• Clinical and molecular characterization of patients with juvenile myelomonocytic leukaemia
  di: Julia A. Meyer, et al.
  Pubblicazione: (2025)